Eli Lilly hikes Mounjaro prices in the UK
Digest more
Drugmaker Eli Lilly says after successful results in a phase 3 clinical trial, it expects to submit a GLP-1 weight loss pill for FDA approval by the end of the year. The pill does not produce the same amount of weight loss as injections,
Asda Online Doctor said it had seen a 350 per cent increase in demand for Mounjaro since Lilly announced the price rise on Thursday, while London-based MedExpress said it had seen a 40 per cent jump in orders, compared with a normal day. MedExpress’s website slowed as customers rushed to buy the drug, because of the “significant uptick in traffic”.